Company Analysis Morepen Laboratories Limited
1. Summary
Disadvantages
- Price (38.42 βΉ) is higher than fair price (30.35 βΉ)
- Dividends (0.48%) are below the sector average (0.6%).
- The stock's return over the last year (-39.15%) is lower than the sector average (-7.22%).
- Current debt level 5.91% has increased over 5 years from 2.03%.
- The company's current efficiency (ROE=10.21%) is lower than the sector average (ROE=15.65%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Morepen Laboratories Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.4% | -1.8% | -2.1% |
| 90 days | -17.8% | -8.2% | -3.8% |
| 1 year | -39.2% | -7.2% | 7% |
MOREPENLAB vs Sector: Morepen Laboratories Limited has significantly underperformed the "Healthcare" sector by -31.93% over the past year.
MOREPENLAB vs Market: Morepen Laboratories Limited has significantly underperformed the market by -46.17% over the past year.
Stable price: MOREPENLAB is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: MOREPENLAB with weekly volatility of -0.75% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (38.42 βΉ) is higher than the fair price (30.35 βΉ).
Price is higher than fair: The current price (38.42 βΉ) is 21% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (17.32) is lower than that of the sector as a whole (92.88).
P/E vs Market: The company's P/E (17.32) is lower than that of the market as a whole (49.45).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.77) is lower than that of the sector as a whole (6.05).
P/BV vs Market: The company's P/BV (1.77) is lower than that of the market as a whole (5.93).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (1.12) is lower than that of the sector as a whole (11.44).
P/S vs Market: The company's P/S indicator (1.12) is lower than that of the market as a whole (12.72).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.11) is lower than that of the sector as a whole (17).
EV/Ebitda vs Market: The company's EV/Ebitda (14.11) is lower than that of the market as a whole (25.32).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.31% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.31%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-4.88%).
6.4. ROE
ROE vs Sector: The company's ROE (10.21%) is lower than that of the sector as a whole (15.65%).
ROE vs Market: The company's ROE (10.21%) is higher than that of the market as a whole (6.66%).
6.6. ROA
ROA vs Sector: The company's ROA (6.64%) is lower than that of the sector as a whole (7.48%).
ROA vs Market: The company's ROA (6.64%) is higher than that of the market as a whole (2.25%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.57%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (17.74%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.48% is below the average for the sector '0.6%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.48% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0.48% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
